Britannia Life Sciences Inc. (CSE:BLAB)
Canada
· Delayed Price · Currency is CAD 0.0900
+0.0050 (5.88%)
Dec 4, 2025, 5:26 PM EST
Britannia Life Sciences Cash Flow Statement
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
| Net Income | 8.22 | 7.39 | -4.77 | 5.08 | -15.46 | -0.16 | Upgrade
|
| Depreciation & Amortization | -0.08 | -0.08 | -0.04 | 0.16 | 0.19 | 0.04 | Upgrade
|
| Other Amortization | 0.14 | 0.14 | 0.1 | 0.07 | 0 | 0 | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.78 | -0.23 | -0.47 | -1.39 | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | 3.17 | 2.09 | 0.96 | 0.02 | 0 | - | Upgrade
|
| Stock-Based Compensation | - | - | 0.23 | 1.05 | 1.11 | - | Upgrade
|
| Other Operating Activities | -11.93 | -11.94 | 2.55 | -2.57 | 16.5 | 0.22 | Upgrade
|
| Change in Accounts Receivable | 0.1 | -0.09 | 0.17 | 0.2 | -0.1 | -0.24 | Upgrade
|
| Change in Inventory | 0.19 | 0.18 | 0.07 | - | - | - | Upgrade
|
| Change in Accounts Payable | -0.12 | 0.99 | 0.3 | -0.65 | 0.62 | -0.45 | Upgrade
|
| Change in Other Net Operating Assets | -0.18 | -0.01 | 0.01 | 0.04 | -0.05 | - | Upgrade
|
| Operating Cash Flow | -4.4 | -2.62 | 2.09 | 2.01 | 2.8 | -0.59 | Upgrade
|
| Operating Cash Flow Growth | - | - | 4.15% | -28.26% | - | - | Upgrade
|
| Capital Expenditures | - | - | - | -0.06 | -0.09 | 0.04 | Upgrade
|
| Cash Acquisitions | -0.76 | -0.76 | -1.1 | -2.98 | 0.74 | -4.96 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | -0.29 | - | - | Upgrade
|
| Investment in Securities | -5.54 | -0.29 | - | - | - | - | Upgrade
|
| Other Investing Activities | 12.51 | 12.33 | -0.34 | - | - | - | Upgrade
|
| Investing Cash Flow | 6.2 | 11.27 | -1.44 | -3.32 | 0.65 | -4.91 | Upgrade
|
| Short-Term Debt Issued | - | - | 0.03 | - | 0.12 | 0.23 | Upgrade
|
| Long-Term Debt Issued | - | 0.72 | - | 7.98 | 1.41 | 6 | Upgrade
|
| Total Debt Issued | -0.05 | 0.72 | 0.03 | 7.98 | 1.53 | 6.22 | Upgrade
|
| Short-Term Debt Repaid | - | -0.02 | - | -4.96 | -3.44 | - | Upgrade
|
| Long-Term Debt Repaid | - | -1.08 | -0.09 | -0.07 | -0.08 | -0.02 | Upgrade
|
| Total Debt Repaid | -1.12 | -1.1 | -0.09 | -5.03 | -3.52 | -0.02 | Upgrade
|
| Net Debt Issued (Repaid) | -1.17 | -0.38 | -0.06 | 2.95 | -1.99 | 6.2 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 0 | - | Upgrade
|
| Other Financing Activities | -0.74 | -1.79 | -1.91 | -0.79 | -0.6 | -0 | Upgrade
|
| Financing Cash Flow | -1.91 | -2.17 | -1.97 | 2.16 | -2.58 | 6.2 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.02 | 0.04 | 0.05 | 0.13 | -0.07 | -0.02 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | 0 | - | - | - | Upgrade
|
| Net Cash Flow | -0.12 | 6.53 | -1.28 | 0.97 | 0.8 | 0.69 | Upgrade
|
| Free Cash Flow | -4.4 | -2.62 | 2.09 | 1.95 | 2.71 | -0.54 | Upgrade
|
| Free Cash Flow Growth | - | - | 7.10% | -27.99% | - | - | Upgrade
|
| Free Cash Flow Margin | -1687.88% | -709.38% | 404.71% | 30.50% | 37.16% | -38.15% | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.02 | 0.01 | 0.01 | 0.03 | -0.01 | Upgrade
|
| Cash Interest Paid | - | - | - | 0.79 | - | - | Upgrade
|
| Levered Free Cash Flow | -8.24 | -6.88 | 5.19 | 0.43 | 1.79 | 0.41 | Upgrade
|
| Unlevered Free Cash Flow | -8.18 | -6.82 | 5.25 | 0.96 | 3.24 | 0.63 | Upgrade
|
| Change in Working Capital | -0 | 1.07 | 0.55 | -0.42 | 0.46 | -0.69 | Upgrade
|
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.